VERTEX PHARMACEUTICALS INC / MA ($VRTX)
Filing Information
| Accession Number | 0000875320-26-000102 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 23, 2026 |
| Document | View SEC Filing |
Transactions
12
Total Shares
155,623
Total Value
$35,825,336.90
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
EVP Chief Patient & Ext Af Off | Common Stock | โ | Feb 19, 2026 | Exercise/Conversion | 23,479 | $155.57 | $3,652,628.03 | 92,521 | Direct | โ | View Details | |
EVP Chief Patient & Ext Af Off | Common Stock | โ | Feb 19, 2026 | Exercise/Conversion | 25,026 | $187.53 | $4,693,125.78 | 117,547 | Direct | โ | View Details | |
EVP Chief Patient & Ext Af Off | Common Stock | โ | Feb 19, 2026 | Sale | 920 | $463.91 | $426,797.20 | 116,627 | Direct | โ | View Details | |
EVP Chief Patient & Ext Af Off | Common Stock | โ | Feb 19, 2026 | Sale | 2,730 | $465.05 | $1,269,586.50 | 113,897 | Direct | โ | View Details | |
EVP Chief Patient & Ext Af Off | Common Stock | โ | Feb 19, 2026 | Sale | 1,848 | $465.80 | $860,798.40 | 112,049 | Direct | โ | View Details | |
EVP Chief Patient & Ext Af Off | Common Stock | โ | Feb 19, 2026 | Sale | 10,263 | $467.75 | $4,800,518.25 | 101,786 | Direct | โ | View Details | |
EVP Chief Patient & Ext Af Off | Common Stock | โ | Feb 19, 2026 | Sale | 19,662 | $468.57 | $9,213,023.34 | 82,124 | Direct | โ | View Details | |
EVP Chief Patient & Ext Af Off | Common Stock | โ | Feb 19, 2026 | Sale | 7,241 | $469.61 | $3,400,446.01 | 74,883 | Direct | โ | View Details | |
EVP Chief Patient & Ext Af Off | Common Stock | โ | Feb 19, 2026 | Sale | 11,712 | $470.54 | $5,510,964.48 | 63,171 | Direct | โ | View Details | |
EVP Chief Patient & Ext Af Off | Common Stock | โ | Feb 19, 2026 | Sale | 4,237 | $471.43 | $1,997,448.91 | 58,934 | Direct | โ | View Details | |
EVP Chief Patient & Ext Af Off | Stock Option (Right to Buy) | Derivative | Feb 19, 2026 | Exercise/Conversion | 23,479 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
EVP Chief Patient & Ext Af Off | Stock Option (Right to Buy) | Derivative | Feb 19, 2026 | Exercise/Conversion | 25,026 | $0.00 | $0.00 | 0 | Direct | โ | View Details |